Application segmentation in the Oxygen Concentrator for Pets segmentation framework isolates demand drivers across three clinical settings. Emergency & Critical Care dominates, generating 52 % of 2023 sectoral revenue as concentrators offset hypoxemia during trauma, post-surgical recovery, or acute respiratory distress; units here require 5โ10 L/min continuous flow and battery back-up, pushing ASP above USD 1,100. Home Therapy, representing 34 %, is expanding fastest (CAGR 9.4 %) because owners favour lower-cost, sub-5 kg portable concentrators for chronic bronchitis or feline asthma management, cutting clinic revisit costs. Veterinary Hospitals account for the residual 14 %; despite lower volume, procurement is driven by multi-parameter anaesthesia workstations that integrate concentrators, sustaining steady replacement demand every 4โ5 years and anchoring service-contract revenue for OEMs.